216 related articles for article (PubMed ID: 28693252)
21. Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses.
Sung HH; Park BK; Kim CK; Choi HY; Lee HM
Int J Hyperthermia; 2012; 28(3):227-34. PubMed ID: 22515344
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Combined Embolization and Radiofrequency Ablation in Stage 1 Renal Cell Carcinomas.
Wessendorf J; König AM; Heers H; Mahnken AH
Rofo; 2022 Sep; 194(9):1020-1025. PubMed ID: 35272357
[TBL] [Abstract][Full Text] [Related]
24. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
26. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
28. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
Ma Y; Bedir S; Cadeddu JA; Gahan JC
BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous thermal ablation for renal cell carcinoma in patients with Birt-Hogg-Dubé syndrome.
Matsui Y; Hiraki T; Gobara H; Iguchi T; Tomita K; Uka M; Araki M; Nasu Y; Furuya M; Kanazawa S
Diagn Interv Imaging; 2019 Nov; 100(11):671-677. PubMed ID: 31302073
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
33. The effectiveness of RENAL nephrometry score in ablated renal tumors via radiofrequency ablation or cryoablation.
Aladağ Kurt S; Yücel C; Özhan Oktar S; Erbaş G; Sözen S; Öner AY
Turk J Med Sci; 2019 Jun; 49(3):761-768. PubMed ID: 31062941
[TBL] [Abstract][Full Text] [Related]
34. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
[TBL] [Abstract][Full Text] [Related]
35. Surveillance post-radiofrequency ablation for small renal masses: Recurrence and followup.
Lam CJ; Wong NC; Voss M; Mironov O; Connolly M; Matsumoto ED; Kapoor A
Can Urol Assoc J; 2020 Dec; 14(12):398-403. PubMed ID: 32574144
[TBL] [Abstract][Full Text] [Related]
36. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study.
Hasegawa T; Yamanaka T; Gobara H; Miyazaki M; Takaki H; Sato Y; Inaba Y; Yamakado K
Jpn J Radiol; 2018 Sep; 36(9):551-558. PubMed ID: 29968201
[TBL] [Abstract][Full Text] [Related]
37. Renal Cell Carcinoma Perfusion before and after Radiofrequency Ablation Measured with Dynamic Contrast Enhanced MRI: A Pilot Study.
Wah TM; Sourbron S; Wilson DJ; Magee D; Gregory WM; Selby PJ; Buckley DL
Diagnostics (Basel); 2018 Jan; 8(1):. PubMed ID: 29316711
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of radiofrequency ablation for kidney cancer.
Park S; Cadeddu JA
Cancer Control; 2007 Jul; 14(3):205-10. PubMed ID: 17615525
[TBL] [Abstract][Full Text] [Related]
40. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up.
Beland MD; Wolf FJ; Grand DJ; Dupuy DE; Mayo-Smith WW
AJR Am J Roentgenol; 2011 Sep; 197(3):671-5. PubMed ID: 21862810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
